CN Patent

CN110022875A — 治疗性抑制化合物

Assigned to PHARMACEUTICAL CO · Expires 2019-07-16 · 7y expired

What this patent protects

本文提供了可用于抑制血浆激肽释放酶的杂环衍生化合物和包含所述化合物的药物组合物。此外，本发明化合物和组合物可用于治疗与对血浆激肽释放酶抑制的抑制相关的疾病，如血管性水肿等。

USPTO Abstract

本文提供了可用于抑制血浆激肽释放酶的杂环衍生化合物和包含所述化合物的药物组合物。此外，本发明化合物和组合物可用于治疗与对血浆激肽释放酶抑制的抑制相关的疾病，如血管性水肿等。

Drugs covered by this patent

Patent Metadata

Patent number
CN110022875A
Jurisdiction
CN
Classification
—
Expires
2019-07-16
Drug substance claim
No
Drug product claim
No
Assignee
PHARMACEUTICAL CO
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.